At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Meibomian Gland Dysfunction (MGD) and Tear Cytokines After Cataract Surgery According to Preoperative Meibomian Gland Status
In Brief
An observational study for Cataract. Completed, enrolled 50 participants across 1 site.
Detailed Summary
To investigate the possible mechanisms by which cataract surgery aggravates meibomian gland dysfunction (MGD), the investigators evaluated the changes in tear cytokines and ocular surface parameters after cataract surgery according to the preoperative MGD grade.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartMar 2015
First PostedApr 2015
Primary CompletionAug 2015
TodayJul 2026
First PostedApr 8, 2015
Enrollment StartMar 16, 2015
Primary CompletionAug 3, 2015
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 11.2 years ago